HK Stock MarketDetailed Quotes

01177 SINO BIOPHARM

Watchlist
  • 3.320
  • -0.030-0.90%
Not Open Feb 19 16:08 CST
62.39BMarket Cap13.89P/E (TTM)

SINO BIOPHARM Key Stats

SINO BIOPHARM Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 31, 20222021/Q46.254B / 6.192B--
--2021/Q36.254B / 6.448B--
Aug 31, 20212021/Q27.111B / 7.370B--
May 24, 20212021/Q17.243B / 6.399B--
Mar 23, 20212020/Q45.521B / 6.237B--
DatePeriodRevenue/EstimateEarnings Call
Mar 31, 20222021/Q46.254B / 6.192B--
--2021/Q36.254B / 6.448B--
Aug 31, 20212021/Q27.111B / 7.370B--
May 24, 20212021/Q17.243B / 6.399B--
Mar 23, 20212020/Q45.521B / 6.237B--

Unlock Free Earnings Estimates

SINO BIOPHARM Earnings Reports

Read more

Trending Stocks
HK Dividend Stocks HK Dividend Stocks

Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data. Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 19, 2025

Strong Buy

  • Strong Buy

    94.12%
  • Buy

    5.88%
  • Hold

    0.00%
  • Underperform

    0.00%
  • Sell

    0.00%

Price Target

No Data